Tianjin University files China's first non-invasive BCI study under new biomedical technology rules
A study combining a non-invasive BCI, spinal cord stimulation and an exoskeleton for chronic stroke completed filing under China's State Council Order No. 818 on November 4.
The Brain-Computer Interaction and Human-Machine Integration Haihe Laboratory at Tianjin University says its stroke rehabilitation study completed filing on November 4 under State Council Order No. 818, China’s regulation on clinical research with new biomedical technologies, which took effect in May 2026. The exploratory safety and feasibility study, at Tianjin Huanhu Hospital, targets lower-limb movement problems in people with chronic stroke whose recovery has plateaued. It combines a non-invasive BCI that decodes motor imagery, spinal cord stimulation and a hybrid exoskeleton. Beijing PINS Medical is among the co-preparers.
The lab calls it the first non-invasive BCI project to complete filing under the rules. The report gives no participant numbers, and results are not yet available.
Learn more: Motor imagery · Clinical trial pathway